Charlotte Kirby Charlotte Kirby

Stemnovate set for take-off after being grounded by Covid

It would be considered vulgar in some quarters to call it a rags to riches story, given the quality of the relevant company’s liver-on-chip technology but the financial bounceback of Stemnovate represents a remarkable upturn in fortunes nevertheless.

Read More
Charlotte Kirby Charlotte Kirby

Arecor goes from strength to strength

Upbeat Arecor Therapeutics, the Cambridge biopharma company, reveals it is continuing discussions with potential partners to expand its portfolio of revenue generating partnership deals.

Read More